跳至主要内容
临床试验/KCT0007090
KCT0007090尚未招募未知

Evaluation of the safety, efficacy, and economic evaluation of complex chuna treatment versus simple chuna treatment for non-acute low back pain accompanied by pelvic deviation: randomized, accessor-blind, multicenter pilot clinical trial

Pusan National University Korean Medicine Hospital0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19?(Year) 至 65?(Year)(—)
性别
All

入选标准

  • Inclusion criteria
  • 1. patient having pelvic deviation with non-acute low back pain(onset before more than 2 weeks) and Numeric Rating Scale score above 5
  • 2. patient who has been confirmed to have pelvic deviation by manual diagnose of Korean Medicine dictor using X-ray
  • 3. aged above 19 and below 65
  • 4. patient who is capable of ordinary communication
  • 5. participant who has signed the clinical trail consent form with voluntary participation decision

排除标准

  • Exclusion criteria
  • 1. patient who is diagnosed with specific severe disease which could cause low back pain, or the cause of low back pain is not pelvic deviation (vertebral metastasis of tumor, acute fracture and dislocation, polio, etc.)
  • 2. 2. patient with absolute contraindication of Chuna Manual Therapy(acute cauda equina syndrome, vertebral dislocation, cerebral aneurysm, etc.)
  • 3. patient who is considered inappropriate for the clinical trial by the staffs(e.g. lumbosacropelvic operation history, knee operation history, innate vertebral disease, nerve root block operation history, etc.)
  • 4. patient who has received Chuna Manual Therapy within a week, or taking medicine such as steroids, immunodepressant, mental disorder medicine, or other drugs which could affect study result(e.g.NSAIDs)
  • 5. operation or medical procedure is scheduled which could affect judgement of clinical trial result during the treatment period
  • 6. patient with chronic disease which could affect the effect of the clinical study : cardiovascular disease, kidney disease, diabetic neuropathy, dementia, epilepsy, etc.
  • 7. patient who has participated other clinical trials within 1 month
  • 8. patient who is incapable of ordinary communication because of dementia or mild cognition disorder, etc.
  • 9. pregnant women
  • 10. person who has difficulty with signing the clinical trial consent form or is considered incapable of carrying out the normal clinical trial procedure

研究者

发起方
Pusan National University Korean Medicine Hospital

相似试验

尚未招募
不适用
Evaluation of the safety, efficacy and cost-effectiveness of transcatheter tricuspid valve repair in patients with severe tricuspid regurgitation in the Netherlands.Severe Tricuspid valve Regurgitation (TR) - severe leaking right heart valve10046973
NL-OMON53966Sint Antonius Ziekenhuis150
已完成
不适用
The efficacy, safety and cost-effectiveness analysis of morphine and hydromorphone in intrathecal drug deliver system for intractable cancer paiCancer painCancer
ISRCTN17751043Chinese association for the study of pain, the minimally invasive interventional group240
招募中
不适用
Evaluation of the safety, effectiveness and natural care approach of the Jauni phototherapy romper.icterusJaundice10019654
NL-OMON56682Erasmus MC, Universitair Medisch Centrum Rotterdam12
尚未招募
3 期
The study evaluating the efficacy, safety and economic evaluation of Thai medical marijuana productsEfficacy and safety of 2 different Thai medical marijuana products compared to placebo in palliative care patientsEconomic cost and benefit of Thai marijuana productsMarijuanaCBDTHCCannabinoidCannabidolCanabisPalliativeSupportiveAdvance-stageMetastasisCancer.
TCTR20210712003Dr. Pongtorn Chantharatsami668
进行中(未招募)
1 期
Evaluation of the therapeutic potential of a low-dose therapy with the interleukin-2 analogue Aldesleukin (Proleukin®) in the treatment of systemic lupus erythematosus.Patients with systemic lupus erythematosus (SLE) and increased disease activity refractory to standard therapies.MedDRA version: 18.0Level: PTClassification code 10042945Term: Systemic lupus erythematosusSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 18.0Level: PTClassification code 10067657Term: Systemic lupus erythematosus disease activity index increasedSystem Organ Class: 10022891 - Investigations
EUCTR2013-001599-40-DECharité - Universitätsmedizin Berlin12